Synonym(s):
oxytetracycline; Terramycin; 79-57-2; Oxyterracine; Oxytetracyclin; Oxymycin; Terrafungine; Oxyterracin; Oxitetraciclina; Oxitetracyclin; Adamycin; Biostat; Geomycin; Ryomycin; Oxitetracyclinum; Oxytetracyclinum; Oxytetracycline (anhydrous); Oxyterracyne; Oxytetracycline anhydrous; Solkaciclina; Dabicycline; Fanterrin; Geotilin; Imperacin; Lenocycline; Oksisyklin; Proteroxyna; Riomitsin; Terramitsin; Ursocyclin; Ursocycline; Oxypam; Tarocyn; Tarosin; Teravit; Tetran; Antibiotic TM 25; Oxytetracycline amphoteric; 5-Hydroxytetracycline; Liquamycin LA 200; Biostat PA; Bisolvomycin; Oxysteclin; Oxymykoin; Vendarcin; Ossitetraciclina; Pennox 200; Oxytetracycline (Terramycin); Oxytetracycline [INN]; Berkmycen; Mycoshield TMQTHC 20; Oxytetracycline base; Dalimycin; Oxacycline; Unimycin; NSC-9169; Oxytetracycline calcium; Stevacin; Macocyn; Medamycin; Oxy-Kesso-tetra; 6153-64-6; UNII-SLF0D9077S; Mepatar; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; OTC (antibiotic); MLS000069429; SLF0D9077S; Tetracycline, 5-hydroxy-; CHEBI:27701; Oxytetracycline (internal use); Stecsolin; Oxydon; TM 5; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-; Oxytetracid; E703; NCI-C56473; SMR000059000; Terramycin im; NSC 9169; Terramycin Q50; Q63393012; Ossitetraciclina [DCIT]; Oxytetracyclinum [INN-Latin]; Oxitetraciclina [INN-Spanish]; Terramicina Oftalmica; 79-57-2 (ANHYDROUS); Geomycin (Streptomyces vimosus); HSDB 3145; EINECS 201-212-8; LA 200; BRN 2714587; Embryostat; Galsenomycin; Oxitetracycline; SR-01000003006; Hydroxytetracyclinum; Oxytetracycline,(S); 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-; 5-Hydroxy-Tetracycline; Spectrum_001055; Opera_ID_661; Prestwick0_000307; Prestwick1_000307; Prestwick2_000307; Prestwick3_000307; Spectrum2_000988; Spectrum3_000536; Spectrum4_000466; Spectrum5_001148; Oxytetracycline(Terramycin); SCHEMBL2899; CHEMBL1517; DSSTox_CID_14260; DSSTox_RID_79133; DSSTox_GSID_34260; BSPBio_000274; BSPBio_002151; KBioGR_000912; KBioSS_001535; 4-14-00-02633 (Beilstein Handbook Reference); DivK1c_000225; SCHEMBL560497; SPBio_001055; SPBio_002493; BPBio1_000302; CHEMBL461529; CHEMBL1401333; CHEMBL4280957; DTXSID1034260; NSC9169 (HCL); SCHEMBL13169109; SCHEMBL13782651; GTPL10919; KBio1_000225; KBio2_001535; KBio2_004103; KBio2_006671; KBio3_001651; 6153-64-6 (di-hydrate); NINDS_000225; BDBM241973; (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; HY-B0275; 2058-46-0 (mono-hydrochloride); Tox21_302380; LMPK07000005; MFCD00003700; s1773; ZINC95626782; AKOS015951277; AKOS015961254; ZINC100026355; ZINC100303028; CCG-269334; DB00595; MCULE-5398230579; CAS-79-57-2; IDI1_000225; NCGC00091268-04; NCGC00091268-05; NCGC00091268-06; NCGC00091268-07; NCGC00091268-08; NCGC00091268-09; NCGC00091268-11; NCGC00091268-12; NCGC00188956-01; NCGC00255168-01; AC-12777; AC-13466; S470; 7179-50-2 (calcium (1:1) salt); SBI-0051473.P003; SW196796-3; 3,5,6,10,12,12a-hexahydroxy-6-methyl-; C06624; E75911; Oxytetra Selective Supplement, for microbiology; AB00053514_04; AB00053514_05; AB01274728-01; AB01274728_02; 135740-EP2275422A1; 135740-EP2292608A1; 6153-65-7 (di-hydrochloride salt, di-hydrate); A839720; Q411646; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-; SR-01000003006-5; 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene; Oxytetracycline, British Pharmacopoeia (BP) Reference Standard; Oxytetracycline, European Pharmacopoeia (EP) Reference Standard; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide